Senzime for investors
Senzime develops, manufactures and markets CE- and FDA-cleared patient monitoring systems. The goal is to help eliminate in-hospital complications, and radically reduce healthcare costs related to surgical and high acuity procedures.
Presentation of Q1 2023 report
Annual General meeting 2023
The Annual General Meeting of Senzime AB was held on Tuesday, May 16, 2023, in Uppsala, Sweden.